Blogs

A subset analysis of efficacy and safety outcomes from phase 3 clinical studies of ixekizumab for the treatment of patients with severe plaque psoriasis

By Aesthetic Multispecialty Society posted Apr 21, 2020 12:02 PM

  
.
0 comments
0 views

Permalink